Report Overview

The Global Gram-positive Bacterial Infections Market was valued $US xx Bn in 2019 and is expected to reach US$ xx Bn by 2028, at CAGR of xx% during forecast period of 2019 to 2028



The gram-positive bacterial infections market has been exclusively analysed based on drug type, disease, route of administration, distribution channel, and region. Based on drug type, the global market has been divided into antibiotic, antifungal and others. The antibiotic segment has been further sub-segmented into B-Lactam, quinolones, macrolides, tetracyclines, aminoglycosides, sulphonamides, phenicols, and others. In terms of disease, the global gram-positive bacterial infections market has been segmented into MRSA, pneumonia, sepsis, sinusitis, cellulitis, otitis, pharyngitis, impetigo, and others. Based on route of administration, the global market has been classified into enteral, parenteral, and others. Based on distribution channel, the global gram-positive bacterial infections market has been split into hospital pharmacies, drug stores and retail pharmacies, and others



Market Drivers

The gram-positive bacterial infections market is anticipated to grow in the forecast, owing to increase in the cases of gram-positive bacterial infections and a significant rise in antibacterial resistance. In addition, government initiatives and funding for R&D activities is expected to offer significant growth opportunities in the market during the forecast period. Most infections due to Gram-Positive Organisms can be treated with quite a small number of antibiotics. But rapid increase in number of this infections is booming the Global Gram-positive Bacterial Infections Market